High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia

Dermatologic Surgery

Volumn 31, Issue 1, 2005, Pages 38-42

  Mehrany, Khosrow ^a   Weenig, Roger H ^a   Pittelkow, Mark R ^a   Roenigk, Randall K ^a   Otley, Clark C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CHEMOSURGERY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

EID: 11844270402     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200501000-00008     Document Type: Article

References (27)

1. Mehrany K, Byrd DR, Roenigk RK, et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 2003;29:129-34.
2. Swanson NA. Basal cell carcinoma: treatment modalities and recommendations. Prim Care 1983;10:443-58.
3. Swanson NA. Mohs surgery: technique, indications, applications, and the future. Arch Dermatol 1983;119:761-73.
4. Swanson NA, Grekin RC, Baker SR. Mohs surgery: techniques, indications, and applications in head and neck surgery. Head Neck Surg 1983;6:683-92.
5. Nguyen TH, Ho DQ. Nonmelanoma skin cancer. Curr Treat Options Oncol 2001;3:193-203.
6. Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998;39:698-703.
7. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995;333:1052-7.
8. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 2000;7:223-34.
9. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
10. Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 2001;92:1325-30.
11. Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 1975;232:267-9.
12. Perez-Reyes N, Farhi DC. Squamous cell carcinoma of head and neck in patients with well-differentiated lymphocytic lymphoma. Cancer 1987;59:540-4.
13. Frierson HF Jr, Deutsch BD, Levine PA. Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol 1988;19:1397-402.
14. Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 2004;140:985-8.
15. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-7.
16. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-73.
17. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-90.
18. Weimar VM, Ceilley RI, Goeken JA. Aggressive biologic behavior of basal- and squamous-cell cancers in patients with chronic lymphocytic leukemia or chronic lymphocytic lymphoma. J Dermatol Surg Oncol 1979;5:609-14.
19. Bridges N, Steinberg JJ. Aggressive squamous cell carcinoma of the skin after chronic lymphocytic leukemia. J Surg Oncol 1986;33:27-30.
20. Hartley BE, Searle AE, Breach NM, et al. Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukaemia. J Laryngol Otol 1996;110:694-5.
21. Martinez JC, Otley CC, Stasko T, et al. for the Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003;139:301-6.
22. Kim J, Modlin RL, Moy RL, et al. IL-10 production in cutaneous basal and squamous cell carcinomas: a mechanism for evading the local T cell immune response. J Immunol 1995;155:2240-7.
23. Wong DA, Bishop GA, Lowes MA, et al. Cytokine profiles in spontaneously regressing basal cell carcinomas. Br J Dermatol 2000;143:91-8.
24. Lespi PJ, Gregotini SD. Folliculotropic T cells in regressive basal cell carcinoma of skin. Am J Dermatopathol 2000;22:30-3.
25. Berhane T, Halliday GM, Cooke B, Barnetson RS. Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol 2002;146:810-5.
26. + T cell infiltration, enables murine skin tumours to progress. Cancer Immunol Immunother 2003;52:396-402.
27. + T cells. J Exp Med 2003;197:1017-28.